Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States

被引:8
作者
Su, Jun [1 ]
Bylsma, Lauren C. [2 ]
Jiang, Xiaohui [2 ]
Morales Arias, Jaime [1 ]
Jain, Nisha [1 ]
Nordyke, Robert J. [3 ]
机构
[1] Sanofi, 50 Binney St, Cambridge, MA 02142 USA
[2] EpidStrategies, Ann Arbor, MI USA
[3] Beta6 Consulting Grp, Los Angeles, CA USA
关键词
Disease burden; healthcare resource utilization; cold agglutinin disease; autoimmune hemolytic anemia; database analysis; BURDEN; ANEMIA; COSTS;
D O I
10.1080/13696998.2020.1764006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims: Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia associated with increased thromboembolism risk and early mortality. Healthcare resource utilization (HRU) in CAD has not been reported. We aimed to compare HRU of patients with CAD with a matched non-CAD cohort in the United States. Materials and methods: Patients with CAD were identified from 2006 to 2016 in the Optum-Humedica database using CAD terms in clinical notes and hematologist review. Patients were required to have Integrated Delivery Network records and >= 6 months' follow-up before and after the first CAD mention date (index date). Patients with CAD were matched to a non-CAD cohort based on demographics. Multivariate analyses assessed inpatient hospitalizations, outpatient visits, emergency room visits, and transfusion use between cohorts 6 months before and 12 months after the index date. Results: Of 814 patients with CAD, 410 met inclusion criteria and were matched to 3,390 patients without CAD. Mean age of patients with CAD was 68.0 years; approximately 62% were female. In the 12 months after the index date, mean inpatient hospitalizations (0.83 vs. 0.25), outpatient visits (17.26 vs. 6.77), emergency room visits (0.55 vs. 0.32), and transfusion days (1.05 vs. 0.05) were higher for patients with CAD than the matched non-CAD cohort (all p < .0001). Similarly, in the 6 months before the index date, patients with CAD had higher HRU than matched patients without CAD for all measures evaluated. Limitations: Results of this study are based on patient information from the Optum-Humedica database, which is limited to commercially insured patients and may not represent the overall CAD population. Conclusions: CAD places a substantial burden on patients and healthcare systems. In addition, the high HRU for patients with CAD observed in the 6 months before diagnosis indicates that disease awareness and better diagnostic practices may be needed.
引用
收藏
页码:902 / 907
页数:6
相关论文
共 50 条
  • [31] Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine
    Gilligan, Adrienne M.
    Foster, Shonda A.
    Sainski-Nguyen, Amy
    Sedgley, Robert
    Smith, David
    Morrow, Paula
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2018, 60 (12) : 1120 - 1127
  • [32] Healthcare resource utilization and costs for patients with postoperative atrial fibrillation in the United States
    Park, Tae Jin
    Hansen, Ryan
    Gillard, Patrick
    Shah, Darshini
    Ferguson, William G.
    Piccini, Jonathan
    Romano, Matthew A.
    Devine, Beth
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1417 - 1423
  • [33] Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured population
    Wang, Susanne X.
    Ganguli, Arijit X.
    Bodhani, Amit
    Medema, Jeroen K.
    Reichmann, William M.
    Macaulay, Dendy
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (12) : 1299 - 1306
  • [34] Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany
    Canbay, Ali
    Kachru, Nandita
    Haas, Jennifer Scarlet
    Meise, Dominic
    Ozbay, A. Burak
    Sowa, Jan-Peter
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [35] Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
    Zhang, Dongmu
    Prabhu, Vimalanand S.
    Marcella, Stephen W.
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (09) : 1326 - 1332
  • [36] Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States
    Butzner, Michael
    Rowin, Ethan
    Yakubu, Amin
    Seale, Josiah
    Robertson, Laura A.
    Sarocco, Phil
    Maron, Martin S.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [37] Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014
    Migden, Michael
    Xie, Jipan
    Wei, Jin
    Tang, Wenxi
    Herrera, Vivian
    Palmer, Jacqueline B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (01) : 55 - +
  • [38] Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
    Pepose, Jay S.
    Sarda, Sujata P.
    Cheng, Wendy Y.
    McCormick, Nora
    Cheung, Hoi Ching
    Bobbili, Priyanka
    Joseph, Corey
    Duh, Mei Sheng
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 377 - 387
  • [39] Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B
    Nguyen, Mindie H.
    Ozbay, A. Burak
    Liou, Iris
    Meyer, Nicole
    Gordon, Stuart C.
    Dusheiko, Geoffrey
    Lim, Joseph K.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 24 - 32
  • [40] Multiple sclerosis prevalence in the United States commercially insured population
    Dilokthornsakul, Piyameth
    Valuck, Robert J.
    Nair, Kavita V.
    Corboy, John R.
    Allen, Richard R.
    Campbell, Jonathan D.
    NEUROLOGY, 2016, 86 (11) : 1014 - 1021